Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2021-12-31 |
2021-01-01 to 2021-12-31 |
As at 2020-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification | — |
Biocartis Group
|
— |
| Domicile of entity | — |
België
|
— |
| Legal form of entity | — |
NV
|
— |
| Country of incorporation | — |
België
|
— |
| Address of entity's registered office | — |
Generaal de Wittelaan 11 B 2800 Mechelen
|
— |
| Principal place of business | — |
Mechelen
|
— |
| Description of nature of entity's operations and principal activities | — |
hebben een vernieuwend en eigen moleculair diagnostisch platform (‘MDx’) ontwikkeld, dat accurate, zeer betrouwbare en moleculaire informatie verstrekt over nagenoeg elk biologisch staal en daardoor een sn
|
— |
| Name of parent entity | — |
Biocartis Group NV
|
— |
| Name of ultimate parent of group | — |
Biocartis Group NV
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
16,106
EUR
|
— |
15,712
EUR
|